EZH2 and cancer: To investigate the role of NIC in modulating EMT markers by elevating the level of EZH2 in cancer cells, the cancer cells were first treated with NIC for 72 h and then the NIC-treated cells were transfected with controlsi or EZH2si (in absence of NIC).